Real-time enrollment status for this drug-resistant epilepsy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT06388707 |
| Recruiting Status | Recruiting |
| Condition | Drug-resistant Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 8 participants |
| Active Locations | 3 sites in the US |
| Sponsor | NaviFUS Corporation |
| Last Updated on CT.gov | May 13, 2025 (May 13, 2025) |
As of March 2, 2026: Clinical trial NCT06388707 is currently recruiting participants. This clinical trial study for drug-resistant epilepsy is actively seeking new participants at 3 locations across the United States. The study is sponsored by NaviFUS Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06388707 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06388707 was last updated May 13, 2025 (May 13, 2025). HelloStudys verifies this status automatically.